Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,752 | 10,255 | 12,956 | 2,429 | 3,882 |
| Marketable Securities | N/A | N/A | N/A | 2,000 | 2,000 |
| TOTAL | $8,089 | $10,380 | $13,106 | $4,750 | $6,359 |
| Non-Current Assets | |||||
| PPE Net | 275 | 105 | 114 | 124 | 135 |
| Other Non-Current Assets | 27 | 27 | 177 | 27 | 27 |
| TOTAL | $302 | $132 | $291 | $151 | $162 |
| Total Assets | $8,391 | $10,512 | $13,397 | $4,901 | $6,521 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 741 | 672 | 917 | 457 | 297 |
| Accrued Expenses | 1,713 | 1,593 | 1,625 | 1,408 | 1,256 |
| TOTAL | $2,454 | $2,265 | $2,542 | $1,865 | $1,553 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,454 | $2,265 | $2,542 | $1,865 | $1,553 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | N/A | 1 | 1 |
| Retained earnings | -74,073 | -71,559 | -66,099 | -63,760 | -61,548 |
| Other shareholders' equity | 0 | 0 | 3,525 | 0 | 0 |
| TOTAL | $5,937 | $8,247 | $10,855 | $3,036 | $4,968 |
| Total Liabilities And Equity | $8,391 | $10,512 | $13,397 | $4,901 | $6,521 |